Molecular Testing for COVID-19: What the Clinician Should Know

Authors

Nermin Kamal Saeed^1, , Mohammed Al-Biltagi^{2, 3, *,} , Adel Salah Bediwy^{2, 3,}

¹Pathology Department, Slamanyia Medical Complex, MOH, Bahrain

²Faculty of Medicine, Tanta University, Al Bahr Street, Tanta, Algharbia Province, Egypt

³University Medical Centre, Dr. Sulaiman Alhabib Medical Group, King Abdulla Medical City, Arabian Gulf University, Bahrain

^*Corresponding author. Email: mbelrem@hotmail.com

DOI

10.2991/dsahmj.k.210427.002How to use a DOI?

Keywords

Coronavirus disease 2019; molecular testing; reverse transcription polymerase chain reaction; cycle threshold; viral shedding

Abstract

Coronavirus Disease 2019 (COVID-19) is a major challenge for health systems worldwide. Molecular diagnosis is a cornerstone in the management of COVID-19. Clinicians should understand the various aspects of molecular testing that may influence their judgment and management. Cycle threshold, viral shedding, and recurrence are among the most common areas of conflict among clinicians. In this review, we discuss these areas of conflict from a clinical perspective.

Copyright

© 2021 Dr. Sulaiman Al Habib Medical Group. Publishing services by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

TY  - JOUR
AU  - Nermin Kamal Saeed
AU  - Mohammed Al-Biltagi
AU  - Adel Salah Bediwy
PY  - 2021
DA  - 2021/05/04
TI  - Molecular Testing for COVID-19: What the Clinician Should Know
JO  - Dr. Sulaiman Al Habib Medical Journal
SP  - 53
EP  - 59
VL  - 3
IS  - 2
SN  - 2590-3349
UR  - https://doi.org/10.2991/dsahmj.k.210427.002
DO  - 10.2991/dsahmj.k.210427.002
ID  - Saeed2021
ER  -